Sentences with phrase «global vaccine development»

Among the groups leading the way are those devoted to global vaccine development, which already partner with firms to bring vaccine programs closer to fruition.

Not exact matches

La Montagne chaired the World Health Organization Task Force on Strategic Planning for the Children's Vaccine Initiative, advised the Pan American Health Organization on programs for vaccine - research implementation, and served as a member of the board for the Global Alliance for Tuberculosis Drug DevelVaccine Initiative, advised the Pan American Health Organization on programs for vaccine - research implementation, and served as a member of the board for the Global Alliance for Tuberculosis Drug Develvaccine - research implementation, and served as a member of the board for the Global Alliance for Tuberculosis Drug Development.
The flurry of action — at breakneck speed compared with most vaccine development — shows how a health emergency and a guaranteed global market can prod this process to move a lot faster than usual, with streamlined approvals and millions of dollars in government support.
An internationally - recognized scientist with more than 16 years of experience in translational immunoparasitology research and vaccine development for neglected tropical diseases, Bottazzi's major interest lies in the role of vaccines as control tools integrated into international public and global health programs and initiatives.
For this survey of global health, Science has joined forces with Science Translational Medicine, which examines vaccine development, strategies against emerging infections, progress in point - of - care diagnostics, and ways to promote mental health and neonatal health.
With most of these firms or their vaccine subsidiaries based in Europe, this makes the continent home to 90 per cent of global vaccine production and nearly half of its R&D (Drug Development and Delivery, vol 11, p 26).
Zika virus infection during pregnancy can result in microcephaly and other serious birth defects in the fetus, making the development of a safe and effective vaccine a global health priority.
«The Meningitis Vaccine Project is one of the greatest success stories in public health,» said Dr. Chris Elias, President of the Global Development Program at the Bill & Melinda Gates Foundation, a major funder of the project.
The I» Cubed also makes these tools available to the global community for the development of vaccines for tropical and emerging infectious diseases.
Vinetz said the next step will be to begin exploiting the genomic information «for vaccine and diagnostics development, experimental approaches to understanding mechanisms of disease pathogenesis and how Leptospira persist in the environment, all critical for developing new public health interventions aimed at reducing the global impact of this important but neglected zoonotic disease.»
With this comprehensive approach, TRANSVAC2 functions as a leverage and innovation catalyst between all stakeholders involved in vaccine R&D in Europe, and contributes to the development of effective products to address European and global health challenges.
Previously, Torsten worked for more than 10 years at GlaxoSmithKline Vaccines where he was the Global Head of the Vaccines Transactions Team with responsibility for all vaccine business development activities ranging from collaborations, option and licensing contracts to mergers & acquisitions.
April 7, 2018 - The University of Florida, along with partners in the United States and Japan, received a $ 3.2 million grant from the Global Health Innovative Technology Fund to continue the development of a new malaria vaccine.
TBVI will continue to support global efforts to accelerate TB vaccine discovery and development through increasing innovation, collaboration and coordination.
As the Global HIV Vaccine Product Manager for the US Army, Dr. Ake advances the development of HIV vaccine candidates in preclinical and early clinical sVaccine Product Manager for the US Army, Dr. Ake advances the development of HIV vaccine candidates in preclinical and early clinical svaccine candidates in preclinical and early clinical studies.
1997 — Led the development of HIV vaccines for global deployment — In 1997, MHRP launched the first non-subtype B vaccine study in Thailand.
Alexandre Marques from Brazil's Universidade Federal de Minas Gerais collaborates with M. G. Finn at Georgia Tech on the development of vaccines against potentially deadly tropical diseases that are spreading northward due to global warming.
The Human Vaccines Project is a new public - private partnership, with the goal of accelerating development of improved vaccines and immunotherapies for global infectious diseases and cancers by decoding the human immuneVaccines Project is a new public - private partnership, with the goal of accelerating development of improved vaccines and immunotherapies for global infectious diseases and cancers by decoding the human immunevaccines and immunotherapies for global infectious diseases and cancers by decoding the human immune system.
Global HIV Vaccine Enterprise An alliance of independent organizations dedicated to accelerating the development of a preventive HIV vVaccine Enterprise An alliance of independent organizations dedicated to accelerating the development of a preventive HIV vaccinevaccine.
Dr Odile Leroy, Executive Director of the European Vaccine Initiative (EVI) and coordinator of TRANSVAC2, said: «The TRANSVAC2 activities will further strengthen the vaccine R&D infrastructure in Europe and will thereby accelerate the development of effective vaccines that are urgently needed to address global health challenges&Vaccine Initiative (EVI) and coordinator of TRANSVAC2, said: «The TRANSVAC2 activities will further strengthen the vaccine R&D infrastructure in Europe and will thereby accelerate the development of effective vaccines that are urgently needed to address global health challenges&vaccine R&D infrastructure in Europe and will thereby accelerate the development of effective vaccines that are urgently needed to address global health challenges».
Among other things, it features articles on new developments in HIV cure research, recent studies that show promise but also possible pitfalls of using adenovirus vectors in HIV vaccine candidates, and the funding crisis at the Global Fund to Fight AIDS, Tuberculosis and Malaria.
TRANSVAC is a new infrastructure project - funded by the European Commission in the context of Horizon 2020 - that aims to accelerate the development of effective vaccines urgently needed to address European and global health challenges with the ultimate goal to build an efficient and sustainable collaboration of experts and facilities to catalyse vaccine research in Europe.
«At the WHO, we were looking at vaccine development and implementation from a global policy perspective and forging a broad path forward for the expeditious licensing of an Ebola vaccine
About Zoetis Zoetis, a business unit of Zoetis Inc., is a global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals.
About Pfizer Animal Health Pfizer Animal Health, a business unit of Pfizer Inc., is a global leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic tests.
About Ceva Santé Animale S.A: Ceva Santé Animale is a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for pets, livestock, swine and poultry.
About Ceva Sante Animale: Ceva Sante Animale is a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for pets, livestock, swine and poultry.
Ceva's parent company is a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for pets, livestock, swine and poultry.
About Ceva Santé Animale: Ceva's parent company is a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for pets, livestock, swine and poultry.
Since the development of the first FeLV vaccine, coupled with better management measures (and an increased understanding of virus transmission), global rates of FeLV - related lymphoma have decreased from 70 percent to 15 percent.
About Pfizer Animal Health Pfizer Animal Health, a business unit of Pfizer Inc., is a global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals.
Preparation and global prosecution of patent applications directed to diagnostic and therapeutic products including antibodies, gene therapies, vaccines, stem cells, pharmaceutical formulations, nanotechnology, nucleic acid molecules, biologics, medical devices, mouse platforms for antibody development, and methods of treating diseases.
a b c d e f g h i j k l m n o p q r s t u v w x y z